News
News releases on October 25, 2026
Every news release public companies put out on October 25, 2026 (UTC): 38 news releases, newest first. Open any release to read it.
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of pati...
Johnson & Johnson · Oct 25, 2026
Placing of new shares under general mandate
Alco Holdings Limited · Oct 25, 2026
List of directors and their roles and functions
MicroPort Scientific Corp. · Oct 25, 2026
Resignation of director; and appointment of executive director, chief executive officer and authorised representative
MicroPort Scientific Corp. · Oct 25, 2026
Environmental, Social and Governance Report 2025
Chiho Environmental Group Limited · Oct 25, 2026
2025 Annual Report
Chiho Environmental Group Limited · Oct 25, 2026
Annual results announcement for the year ended 31 December 2025
Chiho Environmental Group Limited · Oct 25, 2026
Environmental, Social and Governance Report 2024
Chiho Environmental Group Limited · Oct 25, 2026
2024 Annual Report
Chiho Environmental Group Limited · Oct 25, 2026
Supplemental announcement in relation to unaudited annual results for the years ended 31 December 2024 and 2025
Chiho Environmental Group Limited · Oct 25, 2026
Annual results announcement for the year ended 31 December 2024
Chiho Environmental Group Limited · Oct 25, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Diksat Transworld Ltd. · Oct 25, 2026
Stock Code: 3587, 83587, 41587 Information
ICBC UBS HK-Global Artificial Intelligence ETF · Oct 25, 2026
Stock Code: 9102, 3102, 83102 Information
ICBC UBS ETF Series - ICBC UBS KraneShares KWEB CSI China Internet ETF · Oct 25, 2026
Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL ...
Agenus Inc. · Oct 25, 2026
Voluntary announcement results from multiple studies of innovative drugs at 2026 esmo congress
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Oct 25, 2026
Further extension of long stop date of discloseable transaction in relation to acquisition of the entire equity interest of the target co...
Apollo Future Mobility Group Limited · Oct 25, 2026
Next Day Disclosure Return
MINISO Group Holding Ltd. · Oct 25, 2026
Profit warning
Sun Art Retail Group Limited · Oct 25, 2026
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
iStreet Network Ltd. · Oct 25, 2026
Resignation of auditor
China Regenerative Medicine International Limited · Oct 25, 2026
Voluntary announcement changes in shareholding structure
Baiwang Co., Ltd. · Oct 25, 2026
Voluntary announcement business update entering into of the strategic procurement agreement
Quantgroup Technology Limited · Oct 25, 2026
Full exercise of the over-allotment option, stabilizing actions and end of stabilization period
Shenzhen Camsense Technologies Co., Ltd. · Oct 25, 2026
End of stabilization period, no stabilizing action and lapse of the over-allotment option
Direct Drive Tech Limited · Oct 25, 2026
Voluntary announcement - cstone announces major clinical validation milestone for CS2009 at esmo 2026: data from more than 300 patients s...
CStone Pharmaceuticals · Oct 25, 2026
Next Day Disclosure Return
Productive Technologies Company Limited · Oct 25, 2026
Voluntary announcement oral presentation of updated clinical data of lbl-034 for relapsed/refractory multiple myeloma at 2026 esmo
Nanjing Leads Biolabs Co., Ltd. · Oct 25, 2026
Arvind Limited has informed the Exchange regarding a press release dated October 25, 2026, titled "Prime Minister Shri Narendra Modi Inau...
Arvind Limited · Oct 25, 2026
Announcement under Regulation 30 (LODR)-Preferential Issue
Bharat Parenterals Ltd. · Oct 25, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Bharat Parenterals Ltd. · Oct 25, 2026
Xencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development...
Xencor, Inc. · Oct 25, 2026
New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell...
Eli Lilly and Company · Oct 25, 2026
Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule
Johnson & Johnson · Oct 25, 2026
BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunothera...
BioNTech SE · Oct 25, 2026
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Re...
Alphalogic Techsys Limited · Oct 25, 2026
Prior Intimation Of Meeting Of The Rights Issue Committee Of Fratelli Vineyards Limited
Fratelli Vineyards Limited · Oct 25, 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Intec Capital Limited · Oct 25, 2026
Prospera Energy Announces Service Rig Update as Luseland Workovers Come Online at 3.3x Prior Rates
Prospera Energy Inc. · Oct 25, 2026